RxSight, Inc.
RXST
$8.43
$0.212.56%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -43.91% | -37.93% | 6.31% | -4.26% | 33.20% |
| Total Depreciation and Amortization | -1.15% | 50.10% | -54.16% | 39.15% | -28.07% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 59.95% | 1.19% | 18.69% | -2.62% | 23.80% |
| Change in Net Operating Assets | 83.68% | -73.89% | -291.32% | 165.34% | 38.59% |
| Cash from Operations | 50.45% | -107.32% | -755.38% | 116.14% | 56.74% |
| Capital Expenditure | -167.30% | 32.11% | 23.21% | 27.58% | 22.57% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -24.46% | 888.92% | 126.57% | 92.85% | -534.90% |
| Cash from Investing | -29.74% | 1,479.92% | 114.25% | 91.99% | -576.42% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 76.92% | -8.33% | -9.09% | 0.00% | 59.26% |
| Issuance of Common Stock | 197.13% | -76.71% | -22.09% | -96.57% | 1,002.54% |
| Repurchase of Common Stock | 100.00% | -- | 100.00% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 100.00% | 31.95% | -- |
| Cash from Financing | 380.95% | -124.70% | 238.95% | -99.21% | 1,294.81% |
| Foreign Exchange rate Adjustments | 133.33% | 150.00% | -271.43% | 800.00% | 66.67% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 9.39% | 46,958.33% | 100.31% | 5.79% | -135.72% |